Concepedia

Britta Göbel

BG

Statistics

Publications

7

Citations

188

H-Index

7

Active since

2010

Affiliations

Sanofi (Germany)(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

University of Padua

University of Lübeck

Britta Göbel is an author at Sanofi (Germany) specializing in pharmacology, glucagon-like peptide-1 receptor agonists, and weight management.

Publications per year

2010–2023

7

Publications

7

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide

Michele Schiavon, R. Visentin, Britta Göbel et al. · Diabetes Obesity and Metabolism · 2021 · 49 citations · Full text

, , +17

Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes

R. Visentin, Michele Schiavon, Britta Göbel et al. · Diabetes Obesity and Metabolism · 2019 · 36 citations

, , +17

<scp>Glucagon‐like peptide</scp>‐1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial

Karen D. Corbin, Elvis Á. Carnero, Timothy D. Allerton et al. · Obesity · 2023 · 27 citations · Full text

, , +17

Linking neuronal brain activity to the glucose metabolism

Britta Göbel, Kerstin M. Oltmanns, Matthias Chung · Theoretical Biology and Medical Modelling · 2013 · 25 citations · Full text

, , +17

Proportional Feedback Control of Energy Intake During Obesity Pharmacotherapy

Kevin D. Hall, Arjun Sanghvi, Britta Göbel · Obesity · 2017 · 24 citations · Full text

, , +16

1–5 of 7